Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Day

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Developmental Neurobiology|July 7, 2025
The Impact of Vitamin A Deficiency and Supplementation on Behavioral and Oxidative Stress Markers in Male Offspring of a Valproic Acid-Induced Autism Rat ModelKacimi Fatima Ezzahra, Ed-Day Soumia, Nechchadi Habiba, et al.
Nutritional Neuroscience|August 13, 2024
Gut microbiota, vitamin A deficiency and autism spectrum disorder: an interconnected trio - a systematic reviewFatima Ezzahra Kacimi, Latifa Didou, Soumia Ed Day, et al.
Journal of Molecular Histology|August 8, 2025
Vitamin A supplementation restores neuroanatomical integrity and behavior in a valproic acid-induced autism modelFatima Ezzahra Kacimi, Hicham Esselmani, Soumia Ed-Day, et al.
Health Technology Assessment (Winchester, England)|February 1, 2019
Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCTJohn Strang, Michael Kelleher, Soraya Mayet, et al.
Psychological Medicine|October 1, 2021
Associations between primary care recorded cannabis use and mental ill health in the UK: a population-based retrospective cohort study using UK primary care dataDeepiksana Keerthy, Joht Singh Chandan, Juste Abramovaite, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|December 13, 2016
Assertive Community Treatment For People With Alcohol Dependence: A Pilot Randomized Controlled TrialColin Drummond, Helen Gilburt, Tom Burns, et al.
European Addiction Research|February 3, 2022
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose WitnessesRebecca McDonald, Sibella Breidahl, Katri Abel-Ollo, et al.
Molecular Biology Reports|May 28, 2026
Erythrina caffra extract restores memory, modulates cholinergic dysfunction, neuroinflammation, and attenuates oxidative stress in cadmium-induced alzheimer's disease-like pathology in ratsSoumia Ed-Day, Fatima Ezzahra Kacimi, Radia El Gui, et al.
The Lancet. Gastroenterology & Hepatology|October 9, 2021
Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referralSteven Masson, Helen Aldersley, Joanna A Leithead, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 16, 2022
Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Developmental Neurobiology|July 7, 2025
The Impact of Vitamin A Deficiency and Supplementation on Behavioral and Oxidative Stress Markers in Male Offspring of a Valproic Acid-Induced Autism Rat ModelKacimi Fatima Ezzahra, Ed-Day Soumia, Nechchadi Habiba, et al.
Nutritional Neuroscience|August 13, 2024
Gut microbiota, vitamin A deficiency and autism spectrum disorder: an interconnected trio - a systematic reviewFatima Ezzahra Kacimi, Latifa Didou, Soumia Ed Day, et al.
Journal of Molecular Histology|August 8, 2025
Vitamin A supplementation restores neuroanatomical integrity and behavior in a valproic acid-induced autism modelFatima Ezzahra Kacimi, Hicham Esselmani, Soumia Ed-Day, et al.
Health Technology Assessment (Winchester, England)|February 1, 2019
Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCTJohn Strang, Michael Kelleher, Soraya Mayet, et al.
Psychological Medicine|October 1, 2021
Associations between primary care recorded cannabis use and mental ill health in the UK: a population-based retrospective cohort study using UK primary care dataDeepiksana Keerthy, Joht Singh Chandan, Juste Abramovaite, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|December 13, 2016
Assertive Community Treatment For People With Alcohol Dependence: A Pilot Randomized Controlled TrialColin Drummond, Helen Gilburt, Tom Burns, et al.
European Addiction Research|February 3, 2022
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose WitnessesRebecca McDonald, Sibella Breidahl, Katri Abel-Ollo, et al.
Molecular Biology Reports|May 28, 2026
Erythrina caffra extract restores memory, modulates cholinergic dysfunction, neuroinflammation, and attenuates oxidative stress in cadmium-induced alzheimer's disease-like pathology in ratsSoumia Ed-Day, Fatima Ezzahra Kacimi, Radia El Gui, et al.
The Lancet. Gastroenterology & Hepatology|October 9, 2021
Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referralSteven Masson, Helen Aldersley, Joanna A Leithead, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 16, 2022
Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Pageof 7